CV
Bayardo J. García-Godoy, DMD, MSc, is a Director of Oral Health Clinical Research at the Colgate-Palmolive Company where he oversees both pre-market and post-market clinical safety and efficacy studies to drive clinically-proven claims globally.
Dr. García-Godoy holds a doctorate degree in Dental Medicine (DMD) from the Universidad Iberoamericana in Santo Domingo, (Dominican Republic), and a Master of Science (MSc) degree from the University of Puerto Rico School of Dental Medicine.
With over 10 years of experience in oral care clinical research, his expertise extends to hands-on clinical evaluation, backed by specialized training and calibration in oral health indices, the management of FDA Clinical Programs, oversight of data management systems, and the dedicated development of research protocols.
Colgate Total Active Prevention: A New Era of SnF2 Stabilized by Nitrate and Phosphates
Despite advancements in oral health care, the burden of oral diseases persists. Daily oral hygiene is an essential public health strategy for maintaining oral health, contributing to the well-being of individuals and preventing the root cause of many common oral diseases associated with a dysbiotic microbiome. Active prevention through the use of advanced oral health products can play a pivotal role in reducing this burden by preventing the onset and progression of oral diseases and the development of potential systemic health issues linked to poor oral hygiene.
Learning Objectives
- Investigate the connection between a dysbiotic oral microbiome and the onset of various oral diseases.
- Explore evidence-based development of a novel stannous-powered formulation that has led to the improved performance benefits expected from modern oral care products.
- Understand the value of preventative oral health multi-benefit regimens to ensure better whole mouth health outcomes.